Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative Studies

Suvina Amin,1 Mena Soliman,2 Andrew McIvor,3 Andrew Cave,4 Claudia Cabrera5 1US Oncology Medical Affairs, AstraZeneca, Gaithersburg, MD, USA; 2BioPharmaceuticals Medical (Europe and Canada), AstraZeneca, Mississauga, ON, Canada; 3Department of Medicine, Firestone Institute for Respiratory Health, St...

Full description

Bibliographic Details
Main Authors: Amin S, Soliman M, McIvor A, Cave A, Cabrera C
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/understanding-patient-perspectives-on-medication-adherence-in-asthma-a-peer-reviewed-article-PPA
_version_ 1819162843426062336
author Amin S
Soliman M
McIvor A
Cave A
Cabrera C
author_facet Amin S
Soliman M
McIvor A
Cave A
Cabrera C
author_sort Amin S
collection DOAJ
description Suvina Amin,1 Mena Soliman,2 Andrew McIvor,3 Andrew Cave,4 Claudia Cabrera5 1US Oncology Medical Affairs, AstraZeneca, Gaithersburg, MD, USA; 2BioPharmaceuticals Medical (Europe and Canada), AstraZeneca, Mississauga, ON, Canada; 3Department of Medicine, Firestone Institute for Respiratory Health, St. Joseph’s Healthcare and McMaster University, Hamilton, ON, Canada; 4Department of Family Medicine, University of Alberta, Edmonton, AL, Canada; 5BioPharmaceuticals Medical (Evidence), AstraZeneca, Gothenburg, SwedenCorrespondence: Suvina AminAstraZeneca, One Medimmune Way, Gaithersburg, MD 20878, USATel +1 800 565 5877Email suvina.amin@astrazeneca.comAbstract: Adherence to asthma medications is generally poor and undermines clinical outcomes. Poor adherence is characterized by underuse of inhaled corticosteroids (ICS), often accompanied by over-reliance on short-acting β2-agonists for symptom relief. To identify drivers of poor medication adherence, a targeted literature search was performed in MEDLINE and EMBASE for articles presenting qualitative data evaluating medication adherence in asthma patients (≥ 12 years old), published from January 1, 2012 to February 26, 2018. A thematic analysis of 21 relevant articles revealed several key themes driving poor medication adherence, including asthma-specific drivers and more general drivers common to chronic diseases. Due to the episodic nature of asthma, many patients felt that their daily life was not substantially impacted; consequently, many harbored doubts about the accuracy of their diagnosis or were in denial about the impact of the disease and, in turn, the need for long-term treatment. This was further compounded by poor patient-physician communication, which contributed to suboptimal knowledge about asthma medications, including lack of understanding of the distinction between maintenance and reliever inhalers, suboptimal inhaler technique, and concerns about ICS side effects. Other drivers of poor medication adherence included the high cost of asthma medication, general forgetfulness, and embarrassment over inhaler use in public. Overall, patients’ perceived lack of need for asthma medications and medication concerns, in part due to suboptimal knowledge and poor patient-physician communication, emerged as key drivers of poor medication adherence. Optimal asthma care and management should therefore target these barriers through effective patient- and physician-centered strategies.Keywords: Inhaled corticosteroids, over-reliance, patient-physician communication, respiratory tract disease, short-acting β2-agonist, underuse
first_indexed 2024-12-22T17:34:41Z
format Article
id doaj.art-597126a956b848a19f9a6a6add7469ac
institution Directory Open Access Journal
issn 1177-889X
language English
last_indexed 2024-12-22T17:34:41Z
publishDate 2020-03-01
publisher Dove Medical Press
record_format Article
series Patient Preference and Adherence
spelling doaj.art-597126a956b848a19f9a6a6add7469ac2022-12-21T18:18:32ZengDove Medical PressPatient Preference and Adherence1177-889X2020-03-01Volume 1454155152417Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative StudiesAmin SSoliman MMcIvor ACave ACabrera CSuvina Amin,1 Mena Soliman,2 Andrew McIvor,3 Andrew Cave,4 Claudia Cabrera5 1US Oncology Medical Affairs, AstraZeneca, Gaithersburg, MD, USA; 2BioPharmaceuticals Medical (Europe and Canada), AstraZeneca, Mississauga, ON, Canada; 3Department of Medicine, Firestone Institute for Respiratory Health, St. Joseph’s Healthcare and McMaster University, Hamilton, ON, Canada; 4Department of Family Medicine, University of Alberta, Edmonton, AL, Canada; 5BioPharmaceuticals Medical (Evidence), AstraZeneca, Gothenburg, SwedenCorrespondence: Suvina AminAstraZeneca, One Medimmune Way, Gaithersburg, MD 20878, USATel +1 800 565 5877Email suvina.amin@astrazeneca.comAbstract: Adherence to asthma medications is generally poor and undermines clinical outcomes. Poor adherence is characterized by underuse of inhaled corticosteroids (ICS), often accompanied by over-reliance on short-acting β2-agonists for symptom relief. To identify drivers of poor medication adherence, a targeted literature search was performed in MEDLINE and EMBASE for articles presenting qualitative data evaluating medication adherence in asthma patients (≥ 12 years old), published from January 1, 2012 to February 26, 2018. A thematic analysis of 21 relevant articles revealed several key themes driving poor medication adherence, including asthma-specific drivers and more general drivers common to chronic diseases. Due to the episodic nature of asthma, many patients felt that their daily life was not substantially impacted; consequently, many harbored doubts about the accuracy of their diagnosis or were in denial about the impact of the disease and, in turn, the need for long-term treatment. This was further compounded by poor patient-physician communication, which contributed to suboptimal knowledge about asthma medications, including lack of understanding of the distinction between maintenance and reliever inhalers, suboptimal inhaler technique, and concerns about ICS side effects. Other drivers of poor medication adherence included the high cost of asthma medication, general forgetfulness, and embarrassment over inhaler use in public. Overall, patients’ perceived lack of need for asthma medications and medication concerns, in part due to suboptimal knowledge and poor patient-physician communication, emerged as key drivers of poor medication adherence. Optimal asthma care and management should therefore target these barriers through effective patient- and physician-centered strategies.Keywords: Inhaled corticosteroids, over-reliance, patient-physician communication, respiratory tract disease, short-acting β2-agonist, underusehttps://www.dovepress.com/understanding-patient-perspectives-on-medication-adherence-in-asthma-a-peer-reviewed-article-PPAinhaled corticosteroidsover-reliancepatient-physician communicationrespiratory tract diseaseshort-acting β2-agonistunderuse.
spellingShingle Amin S
Soliman M
McIvor A
Cave A
Cabrera C
Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative Studies
Patient Preference and Adherence
inhaled corticosteroids
over-reliance
patient-physician communication
respiratory tract disease
short-acting β2-agonist
underuse.
title Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative Studies
title_full Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative Studies
title_fullStr Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative Studies
title_full_unstemmed Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative Studies
title_short Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative Studies
title_sort understanding patient perspectives on medication adherence in asthma a targeted review of qualitative studies
topic inhaled corticosteroids
over-reliance
patient-physician communication
respiratory tract disease
short-acting β2-agonist
underuse.
url https://www.dovepress.com/understanding-patient-perspectives-on-medication-adherence-in-asthma-a-peer-reviewed-article-PPA
work_keys_str_mv AT amins understandingpatientperspectivesonmedicationadherenceinasthmaatargetedreviewofqualitativestudies
AT solimanm understandingpatientperspectivesonmedicationadherenceinasthmaatargetedreviewofqualitativestudies
AT mcivora understandingpatientperspectivesonmedicationadherenceinasthmaatargetedreviewofqualitativestudies
AT cavea understandingpatientperspectivesonmedicationadherenceinasthmaatargetedreviewofqualitativestudies
AT cabrerac understandingpatientperspectivesonmedicationadherenceinasthmaatargetedreviewofqualitativestudies